Frontiers in Cellular and Infection Microbiology-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1226488, encodeId=d58812264881f, content=投稿命中率:25.0 偏重的研究方向：肠道微生物 经验分享：转投过来的，一直是Initial Validation，快一周多了，还没有分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d57e5424286, createdName=ms5000001536683150, createdTime=Tue Jun 14 22:00:41 CST 2022, time=2022-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097876, encodeId=2894209e876d9, content=中医复方可以投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230524/e3ba88933c884a168701d3b137e3d34e/9beff8120086481f82b4cff7bfde96f3.jpg, createdBy=f9be4718110, createdName=vietdzung24, createdTime=Tue Nov 01 16:51:40 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241108, encodeId=bce612411087e, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：微生物 经验分享：请问初始评估阶段要求daw data，大家是PCR，WB 所有的daw data都上传嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eeef8166882, createdName=ms5000000620461537, createdTime=Fri Aug 26 10:04:42 CST 2022, time=2022-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234496, encodeId=236f123449627, content=这个期刊是不是水刊啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aabe8248672, createdName=ms3000000928792322, createdTime=Sun Jul 24 22:43:52 CST 2022, time=2022-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229236, encodeId=04e7122923629, content=投稿命中率:25.0 偏重的研究方向：肠道微生物 经验分享：投了一个月了，还没有分配编辑，太难了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d57e5424286, createdName=ms5000001536683150, createdTime=Tue Jun 28 18:57:41 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236906, encodeId=13d5123690650, content=这个刊到底怎么样呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aabe8248672, createdName=ms3000000928792322, createdTime=Sat Aug 06 10:52:34 CST 2022, time=2022-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200585, encodeId=e8ef120058551, content=问一下大家，这个期刊要的原始数据是一次的还是三次的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fad24787866, createdName=1206616659, createdTime=Tue Mar 08 16:05:31 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212230, encodeId=e36b1212230b1, content=审稿速度:1.0 偏重的研究方向：病毒学 经验分享：看到有前辈说接收后10天左右给proof，我这已经超过10天了，还没有看到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fbab2010476, createdName=兮牧歌, createdTime=Mon Apr 18 17:10:13 CST 2022, time=2022-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204074, encodeId=069012040e4f8, content=偏重的研究方向：传染病 经验分享：临床传染病，两个审稿人意见不多，很快接受，质量一般, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2ae2794879, createdName=152274b8aam, createdTime=Sat Mar 19 15:52:35 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201134, encodeId=ca61120113409, content=请问下多久under review？10天了还没送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6904820854, createdName=cc2295168, createdTime=Thu Mar 10 08:18:47 CST 2022, time=2022-03-10, status=1, ipAttribution=)]

2022-06-14 ms5000001536683150

投稿命中率:25.0
偏重的研究方向：肠道微生物
经验分享：转投过来的，一直是Initial Validation，快一周多了，还没有分配编辑

73 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1226488, encodeId=d58812264881f, content=投稿命中率:25.0 偏重的研究方向：肠道微生物 经验分享：转投过来的，一直是Initial Validation，快一周多了，还没有分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d57e5424286, createdName=ms5000001536683150, createdTime=Tue Jun 14 22:00:41 CST 2022, time=2022-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097876, encodeId=2894209e876d9, content=中医复方可以投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230524/e3ba88933c884a168701d3b137e3d34e/9beff8120086481f82b4cff7bfde96f3.jpg, createdBy=f9be4718110, createdName=vietdzung24, createdTime=Tue Nov 01 16:51:40 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241108, encodeId=bce612411087e, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：微生物 经验分享：请问初始评估阶段要求daw data，大家是PCR，WB 所有的daw data都上传嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eeef8166882, createdName=ms5000000620461537, createdTime=Fri Aug 26 10:04:42 CST 2022, time=2022-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234496, encodeId=236f123449627, content=这个期刊是不是水刊啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aabe8248672, createdName=ms3000000928792322, createdTime=Sun Jul 24 22:43:52 CST 2022, time=2022-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229236, encodeId=04e7122923629, content=投稿命中率:25.0 偏重的研究方向：肠道微生物 经验分享：投了一个月了，还没有分配编辑，太难了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d57e5424286, createdName=ms5000001536683150, createdTime=Tue Jun 28 18:57:41 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236906, encodeId=13d5123690650, content=这个刊到底怎么样呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aabe8248672, createdName=ms3000000928792322, createdTime=Sat Aug 06 10:52:34 CST 2022, time=2022-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200585, encodeId=e8ef120058551, content=问一下大家，这个期刊要的原始数据是一次的还是三次的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fad24787866, createdName=1206616659, createdTime=Tue Mar 08 16:05:31 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212230, encodeId=e36b1212230b1, content=审稿速度:1.0 偏重的研究方向：病毒学 经验分享：看到有前辈说接收后10天左右给proof，我这已经超过10天了，还没有看到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fbab2010476, createdName=兮牧歌, createdTime=Mon Apr 18 17:10:13 CST 2022, time=2022-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204074, encodeId=069012040e4f8, content=偏重的研究方向：传染病 经验分享：临床传染病，两个审稿人意见不多，很快接受，质量一般, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2ae2794879, createdName=152274b8aam, createdTime=Sat Mar 19 15:52:35 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201134, encodeId=ca61120113409, content=请问下多久under review？10天了还没送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6904820854, createdName=cc2295168, createdTime=Thu Mar 10 08:18:47 CST 2022, time=2022-03-10, status=1, ipAttribution=)]

2022-11-01 vietdzung24

中医复方可以投吗

34 0

[GetPortalCommentsPageByObjectIdResponse(id=1226488, encodeId=d58812264881f, content=投稿命中率:25.0 偏重的研究方向：肠道微生物 经验分享：转投过来的，一直是Initial Validation，快一周多了，还没有分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d57e5424286, createdName=ms5000001536683150, createdTime=Tue Jun 14 22:00:41 CST 2022, time=2022-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097876, encodeId=2894209e876d9, content=中医复方可以投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230524/e3ba88933c884a168701d3b137e3d34e/9beff8120086481f82b4cff7bfde96f3.jpg, createdBy=f9be4718110, createdName=vietdzung24, createdTime=Tue Nov 01 16:51:40 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241108, encodeId=bce612411087e, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：微生物 经验分享：请问初始评估阶段要求daw data，大家是PCR，WB 所有的daw data都上传嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eeef8166882, createdName=ms5000000620461537, createdTime=Fri Aug 26 10:04:42 CST 2022, time=2022-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234496, encodeId=236f123449627, content=这个期刊是不是水刊啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aabe8248672, createdName=ms3000000928792322, createdTime=Sun Jul 24 22:43:52 CST 2022, time=2022-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229236, encodeId=04e7122923629, content=投稿命中率:25.0 偏重的研究方向：肠道微生物 经验分享：投了一个月了，还没有分配编辑，太难了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d57e5424286, createdName=ms5000001536683150, createdTime=Tue Jun 28 18:57:41 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236906, encodeId=13d5123690650, content=这个刊到底怎么样呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aabe8248672, createdName=ms3000000928792322, createdTime=Sat Aug 06 10:52:34 CST 2022, time=2022-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200585, encodeId=e8ef120058551, content=问一下大家，这个期刊要的原始数据是一次的还是三次的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fad24787866, createdName=1206616659, createdTime=Tue Mar 08 16:05:31 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212230, encodeId=e36b1212230b1, content=审稿速度:1.0 偏重的研究方向：病毒学 经验分享：看到有前辈说接收后10天左右给proof，我这已经超过10天了，还没有看到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fbab2010476, createdName=兮牧歌, createdTime=Mon Apr 18 17:10:13 CST 2022, time=2022-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204074, encodeId=069012040e4f8, content=偏重的研究方向：传染病 经验分享：临床传染病，两个审稿人意见不多，很快接受，质量一般, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2ae2794879, createdName=152274b8aam, createdTime=Sat Mar 19 15:52:35 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201134, encodeId=ca61120113409, content=请问下多久under review？10天了还没送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6904820854, createdName=cc2295168, createdTime=Thu Mar 10 08:18:47 CST 2022, time=2022-03-10, status=1, ipAttribution=)]

2022-08-26 ms5000000620461537

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：微生物
经验分享：请问初始评估阶段要求daw data，大家是PCR，WB 所有的daw data都上传嘛

51 0

[GetPortalCommentsPageByObjectIdResponse(id=1226488, encodeId=d58812264881f, content=投稿命中率:25.0 偏重的研究方向：肠道微生物 经验分享：转投过来的，一直是Initial Validation，快一周多了，还没有分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d57e5424286, createdName=ms5000001536683150, createdTime=Tue Jun 14 22:00:41 CST 2022, time=2022-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097876, encodeId=2894209e876d9, content=中医复方可以投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230524/e3ba88933c884a168701d3b137e3d34e/9beff8120086481f82b4cff7bfde96f3.jpg, createdBy=f9be4718110, createdName=vietdzung24, createdTime=Tue Nov 01 16:51:40 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241108, encodeId=bce612411087e, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：微生物 经验分享：请问初始评估阶段要求daw data，大家是PCR，WB 所有的daw data都上传嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eeef8166882, createdName=ms5000000620461537, createdTime=Fri Aug 26 10:04:42 CST 2022, time=2022-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234496, encodeId=236f123449627, content=这个期刊是不是水刊啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aabe8248672, createdName=ms3000000928792322, createdTime=Sun Jul 24 22:43:52 CST 2022, time=2022-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229236, encodeId=04e7122923629, content=投稿命中率:25.0 偏重的研究方向：肠道微生物 经验分享：投了一个月了，还没有分配编辑，太难了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d57e5424286, createdName=ms5000001536683150, createdTime=Tue Jun 28 18:57:41 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236906, encodeId=13d5123690650, content=这个刊到底怎么样呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aabe8248672, createdName=ms3000000928792322, createdTime=Sat Aug 06 10:52:34 CST 2022, time=2022-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200585, encodeId=e8ef120058551, content=问一下大家，这个期刊要的原始数据是一次的还是三次的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fad24787866, createdName=1206616659, createdTime=Tue Mar 08 16:05:31 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212230, encodeId=e36b1212230b1, content=审稿速度:1.0 偏重的研究方向：病毒学 经验分享：看到有前辈说接收后10天左右给proof，我这已经超过10天了，还没有看到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fbab2010476, createdName=兮牧歌, createdTime=Mon Apr 18 17:10:13 CST 2022, time=2022-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204074, encodeId=069012040e4f8, content=偏重的研究方向：传染病 经验分享：临床传染病，两个审稿人意见不多，很快接受，质量一般, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2ae2794879, createdName=152274b8aam, createdTime=Sat Mar 19 15:52:35 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201134, encodeId=ca61120113409, content=请问下多久under review？10天了还没送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6904820854, createdName=cc2295168, createdTime=Thu Mar 10 08:18:47 CST 2022, time=2022-03-10, status=1, ipAttribution=)]

2022-07-24 ms3000000928792322

这个期刊是不是水刊啊

48 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=1226488, encodeId=d58812264881f, content=投稿命中率:25.0 偏重的研究方向：肠道微生物 经验分享：转投过来的，一直是Initial Validation，快一周多了，还没有分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d57e5424286, createdName=ms5000001536683150, createdTime=Tue Jun 14 22:00:41 CST 2022, time=2022-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097876, encodeId=2894209e876d9, content=中医复方可以投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230524/e3ba88933c884a168701d3b137e3d34e/9beff8120086481f82b4cff7bfde96f3.jpg, createdBy=f9be4718110, createdName=vietdzung24, createdTime=Tue Nov 01 16:51:40 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241108, encodeId=bce612411087e, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：微生物 经验分享：请问初始评估阶段要求daw data，大家是PCR，WB 所有的daw data都上传嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eeef8166882, createdName=ms5000000620461537, createdTime=Fri Aug 26 10:04:42 CST 2022, time=2022-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234496, encodeId=236f123449627, content=这个期刊是不是水刊啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aabe8248672, createdName=ms3000000928792322, createdTime=Sun Jul 24 22:43:52 CST 2022, time=2022-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229236, encodeId=04e7122923629, content=投稿命中率:25.0 偏重的研究方向：肠道微生物 经验分享：投了一个月了，还没有分配编辑，太难了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d57e5424286, createdName=ms5000001536683150, createdTime=Tue Jun 28 18:57:41 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236906, encodeId=13d5123690650, content=这个刊到底怎么样呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aabe8248672, createdName=ms3000000928792322, createdTime=Sat Aug 06 10:52:34 CST 2022, time=2022-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200585, encodeId=e8ef120058551, content=问一下大家，这个期刊要的原始数据是一次的还是三次的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fad24787866, createdName=1206616659, createdTime=Tue Mar 08 16:05:31 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212230, encodeId=e36b1212230b1, content=审稿速度:1.0 偏重的研究方向：病毒学 经验分享：看到有前辈说接收后10天左右给proof，我这已经超过10天了，还没有看到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fbab2010476, createdName=兮牧歌, createdTime=Mon Apr 18 17:10:13 CST 2022, time=2022-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204074, encodeId=069012040e4f8, content=偏重的研究方向：传染病 经验分享：临床传染病，两个审稿人意见不多，很快接受，质量一般, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2ae2794879, createdName=152274b8aam, createdTime=Sat Mar 19 15:52:35 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201134, encodeId=ca61120113409, content=请问下多久under review？10天了还没送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6904820854, createdName=cc2295168, createdTime=Thu Mar 10 08:18:47 CST 2022, time=2022-03-10, status=1, ipAttribution=)]

2022-06-28 ms5000001536683150

投稿命中率:25.0
偏重的研究方向：肠道微生物
经验分享：投了一个月了，还没有分配编辑，太难了

50 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1226488, encodeId=d58812264881f, content=投稿命中率:25.0 偏重的研究方向：肠道微生物 经验分享：转投过来的，一直是Initial Validation，快一周多了，还没有分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d57e5424286, createdName=ms5000001536683150, createdTime=Tue Jun 14 22:00:41 CST 2022, time=2022-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097876, encodeId=2894209e876d9, content=中医复方可以投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230524/e3ba88933c884a168701d3b137e3d34e/9beff8120086481f82b4cff7bfde96f3.jpg, createdBy=f9be4718110, createdName=vietdzung24, createdTime=Tue Nov 01 16:51:40 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241108, encodeId=bce612411087e, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：微生物 经验分享：请问初始评估阶段要求daw data，大家是PCR，WB 所有的daw data都上传嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eeef8166882, createdName=ms5000000620461537, createdTime=Fri Aug 26 10:04:42 CST 2022, time=2022-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234496, encodeId=236f123449627, content=这个期刊是不是水刊啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aabe8248672, createdName=ms3000000928792322, createdTime=Sun Jul 24 22:43:52 CST 2022, time=2022-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229236, encodeId=04e7122923629, content=投稿命中率:25.0 偏重的研究方向：肠道微生物 经验分享：投了一个月了，还没有分配编辑，太难了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d57e5424286, createdName=ms5000001536683150, createdTime=Tue Jun 28 18:57:41 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236906, encodeId=13d5123690650, content=这个刊到底怎么样呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aabe8248672, createdName=ms3000000928792322, createdTime=Sat Aug 06 10:52:34 CST 2022, time=2022-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200585, encodeId=e8ef120058551, content=问一下大家，这个期刊要的原始数据是一次的还是三次的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fad24787866, createdName=1206616659, createdTime=Tue Mar 08 16:05:31 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212230, encodeId=e36b1212230b1, content=审稿速度:1.0 偏重的研究方向：病毒学 经验分享：看到有前辈说接收后10天左右给proof，我这已经超过10天了，还没有看到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fbab2010476, createdName=兮牧歌, createdTime=Mon Apr 18 17:10:13 CST 2022, time=2022-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204074, encodeId=069012040e4f8, content=偏重的研究方向：传染病 经验分享：临床传染病，两个审稿人意见不多，很快接受，质量一般, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2ae2794879, createdName=152274b8aam, createdTime=Sat Mar 19 15:52:35 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201134, encodeId=ca61120113409, content=请问下多久under review？10天了还没送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6904820854, createdName=cc2295168, createdTime=Thu Mar 10 08:18:47 CST 2022, time=2022-03-10, status=1, ipAttribution=)]

2022-08-06 ms3000000928792322

这个刊到底怎么样呢

31 0

[GetPortalCommentsPageByObjectIdResponse(id=1226488, encodeId=d58812264881f, content=投稿命中率:25.0 偏重的研究方向：肠道微生物 经验分享：转投过来的，一直是Initial Validation，快一周多了，还没有分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d57e5424286, createdName=ms5000001536683150, createdTime=Tue Jun 14 22:00:41 CST 2022, time=2022-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097876, encodeId=2894209e876d9, content=中医复方可以投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230524/e3ba88933c884a168701d3b137e3d34e/9beff8120086481f82b4cff7bfde96f3.jpg, createdBy=f9be4718110, createdName=vietdzung24, createdTime=Tue Nov 01 16:51:40 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241108, encodeId=bce612411087e, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：微生物 经验分享：请问初始评估阶段要求daw data，大家是PCR，WB 所有的daw data都上传嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eeef8166882, createdName=ms5000000620461537, createdTime=Fri Aug 26 10:04:42 CST 2022, time=2022-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234496, encodeId=236f123449627, content=这个期刊是不是水刊啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aabe8248672, createdName=ms3000000928792322, createdTime=Sun Jul 24 22:43:52 CST 2022, time=2022-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229236, encodeId=04e7122923629, content=投稿命中率:25.0 偏重的研究方向：肠道微生物 经验分享：投了一个月了，还没有分配编辑，太难了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d57e5424286, createdName=ms5000001536683150, createdTime=Tue Jun 28 18:57:41 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236906, encodeId=13d5123690650, content=这个刊到底怎么样呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aabe8248672, createdName=ms3000000928792322, createdTime=Sat Aug 06 10:52:34 CST 2022, time=2022-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200585, encodeId=e8ef120058551, content=问一下大家，这个期刊要的原始数据是一次的还是三次的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fad24787866, createdName=1206616659, createdTime=Tue Mar 08 16:05:31 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212230, encodeId=e36b1212230b1, content=审稿速度:1.0 偏重的研究方向：病毒学 经验分享：看到有前辈说接收后10天左右给proof，我这已经超过10天了，还没有看到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fbab2010476, createdName=兮牧歌, createdTime=Mon Apr 18 17:10:13 CST 2022, time=2022-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204074, encodeId=069012040e4f8, content=偏重的研究方向：传染病 经验分享：临床传染病，两个审稿人意见不多，很快接受，质量一般, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2ae2794879, createdName=152274b8aam, createdTime=Sat Mar 19 15:52:35 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201134, encodeId=ca61120113409, content=请问下多久under review？10天了还没送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6904820854, createdName=cc2295168, createdTime=Thu Mar 10 08:18:47 CST 2022, time=2022-03-10, status=1, ipAttribution=)]

2022-03-08 1206616659

问一下大家，这个期刊要的原始数据是一次的还是三次的。

160 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1226488, encodeId=d58812264881f, content=投稿命中率:25.0 偏重的研究方向：肠道微生物 经验分享：转投过来的，一直是Initial Validation，快一周多了，还没有分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d57e5424286, createdName=ms5000001536683150, createdTime=Tue Jun 14 22:00:41 CST 2022, time=2022-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097876, encodeId=2894209e876d9, content=中医复方可以投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230524/e3ba88933c884a168701d3b137e3d34e/9beff8120086481f82b4cff7bfde96f3.jpg, createdBy=f9be4718110, createdName=vietdzung24, createdTime=Tue Nov 01 16:51:40 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241108, encodeId=bce612411087e, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：微生物 经验分享：请问初始评估阶段要求daw data，大家是PCR，WB 所有的daw data都上传嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eeef8166882, createdName=ms5000000620461537, createdTime=Fri Aug 26 10:04:42 CST 2022, time=2022-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234496, encodeId=236f123449627, content=这个期刊是不是水刊啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aabe8248672, createdName=ms3000000928792322, createdTime=Sun Jul 24 22:43:52 CST 2022, time=2022-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229236, encodeId=04e7122923629, content=投稿命中率:25.0 偏重的研究方向：肠道微生物 经验分享：投了一个月了，还没有分配编辑，太难了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d57e5424286, createdName=ms5000001536683150, createdTime=Tue Jun 28 18:57:41 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236906, encodeId=13d5123690650, content=这个刊到底怎么样呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aabe8248672, createdName=ms3000000928792322, createdTime=Sat Aug 06 10:52:34 CST 2022, time=2022-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200585, encodeId=e8ef120058551, content=问一下大家，这个期刊要的原始数据是一次的还是三次的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fad24787866, createdName=1206616659, createdTime=Tue Mar 08 16:05:31 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212230, encodeId=e36b1212230b1, content=审稿速度:1.0 偏重的研究方向：病毒学 经验分享：看到有前辈说接收后10天左右给proof，我这已经超过10天了，还没有看到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fbab2010476, createdName=兮牧歌, createdTime=Mon Apr 18 17:10:13 CST 2022, time=2022-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204074, encodeId=069012040e4f8, content=偏重的研究方向：传染病 经验分享：临床传染病，两个审稿人意见不多，很快接受，质量一般, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2ae2794879, createdName=152274b8aam, createdTime=Sat Mar 19 15:52:35 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201134, encodeId=ca61120113409, content=请问下多久under review？10天了还没送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6904820854, createdName=cc2295168, createdTime=Thu Mar 10 08:18:47 CST 2022, time=2022-03-10, status=1, ipAttribution=)]

2022-04-18 兮牧歌

审稿速度:1.0
偏重的研究方向：病毒学
经验分享：看到有前辈说接收后10天左右给proof，我这已经超过10天了，还没有看到

49 0

[GetPortalCommentsPageByObjectIdResponse(id=1226488, encodeId=d58812264881f, content=投稿命中率:25.0 偏重的研究方向：肠道微生物 经验分享：转投过来的，一直是Initial Validation，快一周多了，还没有分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d57e5424286, createdName=ms5000001536683150, createdTime=Tue Jun 14 22:00:41 CST 2022, time=2022-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097876, encodeId=2894209e876d9, content=中医复方可以投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230524/e3ba88933c884a168701d3b137e3d34e/9beff8120086481f82b4cff7bfde96f3.jpg, createdBy=f9be4718110, createdName=vietdzung24, createdTime=Tue Nov 01 16:51:40 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241108, encodeId=bce612411087e, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：微生物 经验分享：请问初始评估阶段要求daw data，大家是PCR，WB 所有的daw data都上传嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eeef8166882, createdName=ms5000000620461537, createdTime=Fri Aug 26 10:04:42 CST 2022, time=2022-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234496, encodeId=236f123449627, content=这个期刊是不是水刊啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aabe8248672, createdName=ms3000000928792322, createdTime=Sun Jul 24 22:43:52 CST 2022, time=2022-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229236, encodeId=04e7122923629, content=投稿命中率:25.0 偏重的研究方向：肠道微生物 经验分享：投了一个月了，还没有分配编辑，太难了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d57e5424286, createdName=ms5000001536683150, createdTime=Tue Jun 28 18:57:41 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236906, encodeId=13d5123690650, content=这个刊到底怎么样呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aabe8248672, createdName=ms3000000928792322, createdTime=Sat Aug 06 10:52:34 CST 2022, time=2022-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200585, encodeId=e8ef120058551, content=问一下大家，这个期刊要的原始数据是一次的还是三次的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fad24787866, createdName=1206616659, createdTime=Tue Mar 08 16:05:31 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212230, encodeId=e36b1212230b1, content=审稿速度:1.0 偏重的研究方向：病毒学 经验分享：看到有前辈说接收后10天左右给proof，我这已经超过10天了，还没有看到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fbab2010476, createdName=兮牧歌, createdTime=Mon Apr 18 17:10:13 CST 2022, time=2022-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204074, encodeId=069012040e4f8, content=偏重的研究方向：传染病 经验分享：临床传染病，两个审稿人意见不多，很快接受，质量一般, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2ae2794879, createdName=152274b8aam, createdTime=Sat Mar 19 15:52:35 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201134, encodeId=ca61120113409, content=请问下多久under review？10天了还没送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6904820854, createdName=cc2295168, createdTime=Thu Mar 10 08:18:47 CST 2022, time=2022-03-10, status=1, ipAttribution=)]

2022-03-19 152274b8aam

偏重的研究方向：传染病
经验分享：临床传染病，两个审稿人意见不多，很快接受，质量一般

137 0

[GetPortalCommentsPageByObjectIdResponse(id=1226488, encodeId=d58812264881f, content=投稿命中率:25.0 偏重的研究方向：肠道微生物 经验分享：转投过来的，一直是Initial Validation，快一周多了，还没有分配编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d57e5424286, createdName=ms5000001536683150, createdTime=Tue Jun 14 22:00:41 CST 2022, time=2022-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097876, encodeId=2894209e876d9, content=中医复方可以投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230524/e3ba88933c884a168701d3b137e3d34e/9beff8120086481f82b4cff7bfde96f3.jpg, createdBy=f9be4718110, createdName=vietdzung24, createdTime=Tue Nov 01 16:51:40 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1241108, encodeId=bce612411087e, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：微生物 经验分享：请问初始评估阶段要求daw data，大家是PCR，WB 所有的daw data都上传嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eeef8166882, createdName=ms5000000620461537, createdTime=Fri Aug 26 10:04:42 CST 2022, time=2022-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1234496, encodeId=236f123449627, content=这个期刊是不是水刊啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aabe8248672, createdName=ms3000000928792322, createdTime=Sun Jul 24 22:43:52 CST 2022, time=2022-07-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1229236, encodeId=04e7122923629, content=投稿命中率:25.0 偏重的研究方向：肠道微生物 经验分享：投了一个月了，还没有分配编辑，太难了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d57e5424286, createdName=ms5000001536683150, createdTime=Tue Jun 28 18:57:41 CST 2022, time=2022-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1236906, encodeId=13d5123690650, content=这个刊到底怎么样呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aabe8248672, createdName=ms3000000928792322, createdTime=Sat Aug 06 10:52:34 CST 2022, time=2022-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1200585, encodeId=e8ef120058551, content=问一下大家，这个期刊要的原始数据是一次的还是三次的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fad24787866, createdName=1206616659, createdTime=Tue Mar 08 16:05:31 CST 2022, time=2022-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1212230, encodeId=e36b1212230b1, content=审稿速度:1.0 偏重的研究方向：病毒学 经验分享：看到有前辈说接收后10天左右给proof，我这已经超过10天了，还没有看到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fbab2010476, createdName=兮牧歌, createdTime=Mon Apr 18 17:10:13 CST 2022, time=2022-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1204074, encodeId=069012040e4f8, content=偏重的研究方向：传染病 经验分享：临床传染病，两个审稿人意见不多，很快接受，质量一般, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2ae2794879, createdName=152274b8aam, createdTime=Sat Mar 19 15:52:35 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201134, encodeId=ca61120113409, content=请问下多久under review？10天了还没送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=172, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a6904820854, createdName=cc2295168, createdTime=Thu Mar 10 08:18:47 CST 2022, time=2022-03-10, status=1, ipAttribution=)]

2022-03-10 cc2295168

请问下多久under review？10天了还没送审

172 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务